Medesthetics

JUL-AUG 2018

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link: https://medesthetics.epubxp.com/i/995786

Contents of this Issue

Navigation

Page 12 of 68

10 JULY/AUGUST 2018 | Med Esthetics EDITORIAL ADVISORY BOARD ihansen@creativeage.com • 603.354.3291 In May, the U.S. Food and Drug Administration (FDA) approved Restylane Lyft, a high G-prime hyaluronic acid fi ller for volume replacement in the hands. It is the second fi ller, after Radiesse, and the fi rst HA fi ller to be ap- proved for an off-the-face indication. That same month, Revance Therapeutics added four new management positions to help the company prepare for the commercial launch of its daxibotu- linumtoxinA injectable, RT002. Soft tissue fi ller and neurotoxin treatments make up the majority of nonsurgical cosmetic treatments performed in the U.S. In 2017, more than 2.3 million of the 3.239 million nonsurgi- cal cosmetic procedures performed were injectable treatments. While an expanding patient base explains some of this growth, injectors are also treating more areas than ever before. Gone are the days of adding fi ller to the nasolabial folds and toxins to the glabella to rejuvenate the aging face. Patients today are receiving toxins and fi llers throughout the face, in the neck and in the hands. This raises some questions about how these products interact, what effect increased amounts of product in the body may have on the patient, and how best to train injectors in these more extensive and individualized techniques. For "Global Injections" on page 32, we asked researchers and experienced injectors to share their strategies and fi ndings to help practitioners offer the best outcomes in full-face rejuvenation with injectables. Key to achieving high patient satisfaction rates is training your entire staff—from front desk employees to providers and back offi ce staff—that it is everyone's job to keep patients safe and happy. This includes responding immediately to concerns, whether they relate to a potential complication, poor outcome or less-than-stellar experience with the practice. To learn how aesthetic practices are achieving this, turn to "The Patient-Centric Practice" on page 38. Whether you are working to improve your offerings, outcomes or the patient experience, it always comes back to training. And one signifi cant frustration practice owners may encounter is watching an employee who has benefi ted from hundreds of hours of training at their expense leave to join another practice or start their own aesthetic business. Restrictive covenants, particularly covenants not to compete, are sometimes utilized by practices to reduce this risk. But they have fallen out of favor with many states and courts in the U.S. and they are but one tool available to help protect your business. In "Legal Issues" on page 24, attorney Allyson Avila provides an overview of the different restrictive covenants available to employers and offers guidelines on how to craft an agreement that is fair to all parties and enforceable so you can focus on protecting your patients, your staff and your business. Inga Hansen Executive Editor/Associate Publisher Mary Lee Amerian, MD Medical Director, Santa Monica Laser and Skin Care Center, Santa Monica, CA Bruce Katz, MD Director, Juva Skin & Laser Center, Clinical Professor of Dermatology, Mount Sinai School of Medicine, New York City Joel L. Cohen, MD Director, AboutSkin Dermatology and DermSurgery, CO Associate Clinical Professor of Dermatology, University of Colorado, Assistant Clinical Professor of Dermatology, University of California - Irvine Michael H. Gold, MD Founder, Gold Skin Center, Assistant Clinical Professor, Vanderbilt University Medical Center Nashville, TN Mitchel P. Goldman, MD Medical Director, West Dermatology, Volunteer Clinical Professor of Dermatology, University of California - San Diego Jeannette Graf, MD Assistant Clinical Professor of Dermatology, Mount Sinai Medical Center, New York, NY Lorrie Klein, MD Founder, OC Dermatology & Euro Day Spa, Assistant Clinical Professor of Dermatology, University of California - Irvine Vic Narurkar, MD Founder, Bay Area Laser Institute, Associate Clinical Professor of Dermatology, UC Davis Medical School, Chief of Dermatology, California Pacifi c Medical Center, San Francisco Hema Sundaram, MD Director, Sundaram Dermatology, Cosmetic & Laser Surgery Center Rockville, MD Alex R. Thiersch, JD Founder and Director, American Med Spa Association (AmSpa), Partner, ByrdAdatto Law Firm Chicago Wm. Philip Werschler, MD Director, Spokane Dermatology Clinic and Werschler Aesthetics, Spokane, WA NEW INDICATIONS, NEW QUESTIONS EDITOR'S NOTE

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - JUL-AUG 2018